TORONTO–(BUSINESS WIRE)–FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD” or the “Company”), today announced the appointment of pharmaceutical industry leader, Edward J. Brennan, Jr., M.D., FACS, as President of its biosciences division. Dr. Brennan has more than 25 years’ experience in leadership roles at major pharmaceutical companies and clinical research organizations. “Ed is an accomplished biopharmaceutical executive with a proven track record in FDA submissions and drug ……
http://www.businesswire.com/news/home/20190528005131/en/Edward-Brennan-Jr.-M.D.-FACS-Lead-FSD